Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
Starlight Therapeutics— a Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective...
United States San Francisco Los Angeles Pionyr Immunotherapeutics Marc Chamberlain Norris Cancer Center
Source: marketscreener.com